Stock SELEC SELÇUK ECZA DEPOSU TICARET VE SANAYI
Add to a list
To use this feature you must be a member
Log inSign up

Financials Selçuk Ecza Deposu Ticaret ve Sanayi

Equities

SELEC

TRESLEC00014

Pharmaceuticals

Delayed Borsa Istanbul
Other stock markets
 11:09:41 2024-06-14 EDT 		5-day change 1st Jan Change
45.26 TRY -4.39% Intraday chart for Selçuk Ecza Deposu Ticaret ve Sanayi -8.31% -26.53%
06-12 Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-27 Selçuk Ecza Deposu Ticaret ve Sanayi A.S. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 3,788 8,477 7,328 25,150 38,254 29,464 -
Enterprise Value (EV) 1 3,788 8,477 7,328 25,150 38,254 29,464 29,464
P/E ratio 5.45 x 14.4 x 7.94 x 10.6 x 172 x 5.82 x 4.44 x
Yield - - - - - - -
Capitalization / Revenue 0.21 x 0.4 x 0.28 x 0.56 x 0.39 x 0.23 x 0.17 x
EV / Revenue 0.21 x 0.4 x 0.28 x 0.56 x 0.39 x 0.23 x 0.17 x
EV / EBITDA 4.95 x 11.8 x 6.33 x 8.28 x 7.54 x 4.83 x 3.2 x
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 621,000 621,000 621,000 621,000 621,000 651,000 -
Reference price 2 6.100 13.65 11.80 40.50 61.60 45.26 45.26
Announcement Date 20-02-19 21-02-17 22-02-21 23-02-24 24-02-27 - -
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 17,809 21,027 26,215 44,712 97,719 125,788 170,416
EBITDA 1 764.9 717.5 1,158 3,038 5,075 6,104 9,202
EBIT - - - - - - -
Operating Margin - - - - - - -
Earnings before Tax (EBT) - - - - - - -
Net income 1 694.9 586.8 922.7 2,381 223.2 4,332 6,327
Net margin 3.9% 2.79% 3.52% 5.33% 0.23% 3.44% 3.71%
EPS 2 1.119 0.9450 1.486 3.835 0.3590 7.770 10.19
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 20-02-19 21-02-17 22-02-21 23-02-24 24-02-27 - -
1TRY in Million2TRY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales 1 6,592 8,014 8,568 10,076 11,564 14,504 18,345 17,586
EBITDA 1 219.8 214 655.3 457.4 962.6 962.5 1,285 378.4
EBIT - - - - - - - -
Operating Margin - - - - - - - -
Earnings before Tax (EBT) - - - - - - - -
Net income 1 172.1 203 - 370.6 742.2 719.8 1,078 379.1
Net margin 2.61% 2.53% - 3.68% 6.42% 4.96% 5.87% 2.16%
EPS - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 21-11-09 22-02-21 22-05-10 22-08-12 22-11-09 23-02-24 23-05-10 23-08-15
1TRY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) 25% 17.6% 23.3% 44.3% 1.48% 39.2% 48.2%
ROA (Net income/ Total Assets) 9.33% 6.35% 8.13% 13.9% 0.53% 11% 15.5%
Assets 1 7,444 9,244 11,347 17,152 42,475 39,382 40,819
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - - - - - - -
Capex / Sales - - - - - - -
Announcement Date 20-02-19 21-02-17 22-02-21 23-02-24 24-02-27 - -
1TRY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Selçuk Ecza Deposu Ticaret ve Sanayi

Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
45.26 TRY
Average target price
68.91 TRY
Spread / Average Target
+52.25%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
SELÇUK ECZA DEPOSU TICARET VE SANAYI Stock Selçuk Ecza Deposu Ticaret ve Sanayi
-26.53% 897M
MCKESSON CORPORATION Stock McKesson Corporation
+29.04% 77.66B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+0.15% 24.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+11.60% 8.55B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+2.44% 8.23B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-25.74% 7.43B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+15.20% 5.19B
GALENICA AG Stock Galenica AG
+0.55% 4.05B
EBOS GROUP LIMITED Stock EBOS Group Limited
-10.28% 3.77B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
-5.96% 3.46B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. SELEC Stock
  4. Financials Selçuk Ecza Deposu Ticaret ve Sanayi